The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.
Open accessAbstract
Pulmonary fibrosis is the common end stage of a number of pneumopathies.In this study, we examined the ability of the human cytokine, relaxin, to block extracellular matrix deposition by human lung fibroblasts in vitro, and to inhibit lung fibrosis in a bleomycin-induced murine model.In vitro, relaxin (1-100 ng/ml) inhibited the transforming growth factor- -mediated over-expression of interstitial collagen types I and III by human lung fibroblasts by up to 45% in a dose-dependent manner.Relaxin did not affect basal levels of collagen expression in the absence of TGF- -induced stimulation.Relaxin also blocked transforming growth factor- -induced upregulation of fibronectin by 80% at the highest relaxin dose tested (100 ng/ml).The expression of matrix metalloproteinase-1, or procollagenase, was stimulated in a biphasic, dose-dependent manner by relaxin.In vivo, relaxin, at a steady state circulating concentration of ف 50 ng/ml, inhibited bleomycin-mediated alveolar thickening compared with the vehicle only control group ( P Ͻ 0.05).Relaxin also restored bleomycin-induced collagen accumulation, as measured by lung hydroxyproline content, to normal levels ( P Ͻ 0.05).In summary, relaxin induced a matrix degradative phenotype in human lung fibroblasts in vitro and inhibited bleomycin-induced fibrosis in a murine model in vivo.These data indicate that relaxin may be efficacious in the treatment of pathologies characterized by lung fibrosis.( J. Clin.Invest.1996.98:2739-2745) Key words: pulmonary fibrosis • relaxin • collagen • collagenase MethodsCell culture.Normal human lung fibroblasts obtained from young adult donors were purchased from the American Type Culture Collection (ATCC CCL202, CCL210; Rockville, MD) and passaged according to vendor instructions in MEM supplemented with 10% fetal bovine serum, nonessential amino acids, and 2 mM L-glutamine.Cells were seeded at a density of 1.25 ϫ 10 5 cells/cm 2 in the presence of serum but were switched to MEM supplemented with 0.2% lactalbumin hydrolysate and 2 mM L-glutamine (MEM-LH) for experiments.Reagents and animals.Recombinant human relaxin (Lot M3R-D211 or 9997-96) was manufactured at Genentech, Inc. (South San Francisco, CA) [ 3 H]proline (43 Ci/mmol) was purchased from Amersham (Arlington Heights, IL).Ascorbic acid and  -aminopropionitrile (BAPN) were purchased from Sigma Chemical Co.(St.Louis, MO) and prepared immediately before use as 50 and 80 mg/ml stocks, respectively.Bleomycin (15 U/vial, Blenoxane) (Burns Veterinary
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
Ashcroft, T., Simpson, J. M., & Timbrell, V (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.4.467 · Cited by 1,680
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
Eitzman, D. T., McCoy, R. D., Zheng, X., Fay, W. P., Shen, T., Ginsburg, D., & Simon, R. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118396 · Cited by 558
Khalil, N., O'Connor, R. N., Unruh, H. W., Warren, P. W., Flanders, K. C., Kemp, A., Bereznay, O. H., & Greenberg, A. H. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/5.2.155 · Cited by 521
Khalil, N., Bereznay, O., Sporn, M., & Greenberg, A. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.727 · Cited by 505
Unemori, E. N., & Amento, E. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)87000-4 · Cited by 321
Self-citationTGF-beta: problems and prospects.
Sporn, M. B., & Roberts, A. B. (1990) · Cell Regulation · doi:10.1091/mbc.1.12.875 · Cited by 259
Extracellular matrix and the regulation of lung development and repair 1
McGowan, S. E. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.11.1644255 · Cited by 217
Smith, R. E., Strieter, R. M., Phan, S. H., Lukacs, N. W., Huffnagle, G. B., Wilke, C. A., Burdick, M. D., Lincoln, P., Evanoff, H., & Kunkel, S. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4704 · Cited by 158
Relaxin in human pregnancy serum measured with an homologous radioimmunoassay.
Bell, R. J., EDDIE, L. W., Lester, A., et al. (1987) · PubMed · Cited by 136
Cited by
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Activation of Orphan Receptors by the Hormone Relaxin
Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O. D., & Hsueh, A. J. W. (2002) · Science · doi:10.1126/science.1065654 · Cited by 786
Fibroblast Differentiation in Wound Healing and Fibrosis
Darby, I. A., & Hewitson, T. D. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(07)57004-x · Cited by 600
Relaxin’s Physiological Roles and Other Diverse Actions
Sherwood, O. D. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0013 · Cited by 543
Metadata
- Authors
- Unemori, E. N., Pickford, L. B., Salles, A. L., Piercy, C. E., Grove, B. H., Erikson, M. E., & Amento, E. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-12-15
- Volume
- 98
- Issue
- 12
- Pages
- 2739-2745
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2018314711
- Cited by
- 340
- References
- 25
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. https://app.cochat.ai/papers/10.1172/jci119099
- The paper
- Unemori, E. N., Pickford, L. B., Salles, A. L., Piercy, C. E., Grove, B. H., Erikson, M. E., & Amento, E. P. (1996). Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. Journal of Clinical Investigation. https://doi.org/10.1172/jci119099
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.